Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.40% Nasdaq Up0.97%

Keryx Biopharmaceuticals Inc. (KERX)

14.23 0.37(2.67%) Apr 22, 4:00PM EDT
Get the big picture on all your investments.
Key StatisticsGet Key Statistics for:
Data provided by Capital IQ, except where noted.
Valuation Measures 
Market Cap (intraday)5:1.29B
Enterprise Value (Apr 23, 2014)3:1.17B
Trailing P/E (ttm, intraday):N/A
Forward P/E (fye Dec 31, 2015)1:29.04
PEG Ratio (5 yr expected)1:-0.95
Price/Sales (ttm):180.01
Price/Book (mrq):25.25
Enterprise Value/Revenue (ttm)3:166.85
Enterprise Value/EBITDA (ttm)6:-25.38
Financial Highlights 
Fiscal Year
Fiscal Year Ends:Dec 31
Most Recent Quarter (mrq):Dec 31, 2013
Profit Margin (ttm):N/A
Operating Margin (ttm):-658.33%
Management Effectiveness
Return on Assets (ttm):-72.61%
Return on Equity (ttm):-167.22%
Income Statement
Revenue (ttm):7.00M
Revenue Per Share (ttm):0.09
Qtrly Revenue Growth (yoy):N/A
Gross Profit (ttm):7.00M
EBITDA (ttm)6:-46.03M
Net Income Avl to Common (ttm):-46.73M
Diluted EPS (ttm):-0.58
Qtrly Earnings Growth (yoy):N/A
Balance Sheet
Total Cash (mrq):55.70M
Total Cash Per Share (mrq):0.61
Total Debt (mrq):0.00
Total Debt/Equity (mrq):N/A
Current Ratio (mrq):3.71
Book Value Per Share (mrq):0.55
Cash Flow Statement
Operating Cash Flow (ttm):-34.32M
Levered Free Cash Flow (ttm):-16.65M
View Financials
Income Statement - Balance Sheet - Cash Flow

Trading Information 
Stock Price History
52-Week Change3:71.24%
S&P500 52-Week Change3:19.05%
52-Week High (Mar 31, 2014)3:17.46
52-Week Low (Jun 13, 2013)3:6.61
50-Day Moving Average3:15.32
200-Day Moving Average3:13.72
Share Statistics
Avg Vol (3 month)3:3,171,100
Avg Vol (10 day)3:2,883,120
Shares Outstanding5:90.91M
% Held by Insiders1:2.11%
% Held by Institutions1:66.60%
Shares Short (as of Mar 31, 2014)3:17.02M
Short Ratio (as of Mar 31, 2014)3:5.20
Short % of Float (as of Mar 31, 2014)3:23.80%
Shares Short (prior month)3:16.77M
Dividends & Splits
Forward Annual Dividend Rate4:N/A
Forward Annual Dividend Yield4:N/A
Trailing Annual Dividend Yield3:N/A
Trailing Annual Dividend Yield3:N/A
5 Year Average Dividend Yield4:N/A
Payout Ratio4:N/A
Dividend Date3:N/A
Ex-Dividend Date4:N/A
Last Split Factor (new per old)2:N/A
Last Split Date3:N/A

See Key Statistics Help for definitions of terms used.
Abbreviation Guide: K = Thousands; M = Millions; B = Billions
mrq = Most Recent Quarter (as of Dec 31, 2013)
ttm = Trailing Twelve Months (as of Dec 31, 2013)
yoy = Year Over Year (as of Dec 31, 2013)
lfy = Last Fiscal Year (as of Dec 31, 2013)
fye = Fiscal Year Ending
1 Data provided by Thomson Reuters
2 Data provided by EDGAR Online
3 Data derived from multiple sources or calculated by Yahoo! Finance
4 Data provided by Morningstar, Inc.
5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
6 EBITDA is calculated by Capital IQ using methodology that may differ from that used by a company in its reporting

Currency in USD.